NanoMosaic Secures FDA AMT Designation for Advanced Gene Therapy Analytics NanoMosaic has been awarded the FDA’s Advanced Manufacturing Technology (AMT) designation, a status reserved for platforms that demonstrably improve efficiency, product quality, and regulatory readiness in complex manufacturing environments. This recognition underscores NanoMosaic’s commitment to advancing gene therapy analytics and supporting developers navigating the regulatory…